Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P20807: Variant p.Ser744Gly

Calpain-3
Gene: CAPN3
Feedback?
Variant information Variant position: help 744 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Glycine (G) at position 744 (S744G, p.Ser744Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In LGMDR1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 744 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 821 The length of the canonical sequence.
Location on the sequence: help IKAWQKIFKHYDTDQSGTIN S YEMRNAVNDAGFHLNNQLYD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         IKAWQKIFKHYDTDQSGTINSYEMRNAVNDAGFHLNNQLYD

Mouse                         IKAWQKIFKHYDTDHSGTINSYEMRNAVNDAGFHLNSQLYD

Rat                           IKAWQKIFKHYDTDHSGTINSYEMRNAVNDAGFHLNSQLYD

Pig                           IKSWQKIFKHYDTDQSGTINSYEMRNAVNDAGFHLNNQLYD

Bovine                        IKTWQKIFKHYDTDQSGTINSYEMRNAVKDAGFHLNNQLYD

Sheep                         IKTWQKIFKHYDTDQSGTINSYEMRNAVNDAGFHLNNQLYD

Chicken                       IKSWQKIFKHYDADHSGTINSYEMRNAVKDAGFRLNNQLYD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 821 Calpain-3
Domain 722 – 757 EF-hand 3
Region 650 – 821 Domain IV
Binding site 735 – 735
Binding site 737 – 737
Binding site 739 – 739
Binding site 741 – 741
Binding site 746 – 746
Helix 744 – 753



Literature citations
Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion island.
Fardeau M.; Hillaire D.; Mignard C.; Feingold N.; Feingold J.; Mignard D.; de Ubeda B.; Collin H.; Tome F.M.S.; Richard I.; Beckmann J.S.;
Brain 119:295-308(1996)
Cited for: VARIANTS LGMDR1 GLN-572 AND GLY-744; Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings.
Penisson-Besnier I.; Richard I.; Dubas F.; Beckmann J.S.; Fardeau M.;
Muscle Nerve 21:1078-1080(1998)
Cited for: VARIANT LGMDR1 GLY-744;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.